Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.
Autor: | Copland, J. A.1 coland.john@mayo.edu, Marlow, L. A.1, Kurakata, S.2, Fujiwara, K.2, Wong, A. K. C.3, Kreinest, P. A.1, Williams, S. F.4, Haugen, B. R.5, Klopper, J. P.5, Smallridge, R. C.1,4 |
---|---|
Zdroj: | Oncogene. 4/13/2006, Vol. 25 Issue 16, p2304-2317. 14p. 9 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |